Long-Term Follow-up in Peripartum Cardiomyopathy Patients with Contemporary Treatment: Low Mortality, High Cardiac Recovery, but Significant Cardiovascular Co-Morbidities

Abstract

Our PPCM collective treated with standard therapy for heart failure, dopamine D2 receptor agonists, and anticoagulation displays a high and stable long-term recovery rate with low mortality at 5-year follow-up. However, long-term use of cardiovascular medication, persisting or de novo hypertension and arrhythmias were frequent.